MicroRNA and senescence: the senectome, integration and distributed control - PubMed (original) (raw)
Review
MicroRNA and senescence: the senectome, integration and distributed control
Alan E Bilsland et al. Crit Rev Oncog. 2013.
Abstract
Cellular senescence has attracted renewed interest in recent years in light of the realization that cancer cells are susceptible to senescence-like responses to stress including exposure to chemotherapeutic agents. Therefore, senescence is viewed as a potentially important target in cancer therapy. However, translation of senescence therapeutics will rely on identifying appropriate marker panels for assessing senescence responses in vivo. Although some core pathways governing senescence induction have been clearly identified, the full set of gene targets involved in its establishment and maintenance are not defined and their complex interactions are poorly understood. This view is reinforced by recently discovered roles of microRNA (miRNA) in senescence regulation and induction. Senescence involves coordination of diverse cellular processes ranging from telomere homeostasis and DNA damage to chromatin modifications, inflammatory signaling, and metabolic and cytoskeletal changes. Thus, from a target discovery perspective a "senectome" view is appropriate. miRNAs are well placed to act as distributed senectome control elements, fine-tuning regulation of multiple processes. Here, we examine the complex interactions among several of these subprocesses and subsequently consider senescence-associated miRNAs (SA-miRNAs) as distributed controllers of senectome regulation. Finally, we examine their potential as clinical biomarkers to accelerate development of senescence therapeutics.
Similar articles
- Molecular Regulation of Cellular Senescence by MicroRNAs: Implications in Cancer and Age-Related Diseases.
Neault M, Couteau F, Bonneau É, De Guire V, Mallette FA. Neault M, et al. Int Rev Cell Mol Biol. 2017;334:27-98. doi: 10.1016/bs.ircmb.2017.04.001. Epub 2017 May 18. Int Rev Cell Mol Biol. 2017. PMID: 28838541 Review. - Cancer cell senescence: a new frontier in drug development.
Cairney CJ, Bilsland AE, Evans TR, Roffey J, Bennett DC, Narita M, Torrance CJ, Keith WN. Cairney CJ, et al. Drug Discov Today. 2012 Mar;17(5-6):269-76. doi: 10.1016/j.drudis.2012.01.019. Epub 2012 Jan 31. Drug Discov Today. 2012. PMID: 22314100 Review. - Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkers.
Iguchi H, Kosaka N, Ochiya T. Iguchi H, et al. Curr Drug Discov Technol. 2010 Jun;7(2):95-105. doi: 10.2174/157016310793180648. Curr Drug Discov Technol. 2010. PMID: 20836759 Review. - Pathway analysis of senescence-associated miRNA targets reveals common processes to different senescence induction mechanisms.
Lafferty-Whyte K, Cairney CJ, Jamieson NB, Oien KA, Keith WN. Lafferty-Whyte K, et al. Biochim Biophys Acta. 2009 Apr;1792(4):341-52. doi: 10.1016/j.bbadis.2009.02.003. Epub 2009 Feb 12. Biochim Biophys Acta. 2009. PMID: 19419692 Review. - The impact of cellular senescence in cancer therapy: is it true or not?
Zhang Y, Yang JM. Zhang Y, et al. Acta Pharmacol Sin. 2011 Oct;32(10):1199-207. doi: 10.1038/aps.2011.108. Epub 2011 Sep 12. Acta Pharmacol Sin. 2011. PMID: 21909124 Free PMC article. Review.
Cited by
- Opposing impacts on healthspan and longevity by limiting dietary selenium in telomere dysfunctional mice.
Wu RT, Cao L, Mattson E, Witwer KW, Cao J, Zeng H, He X, Combs GF Jr, Cheng WH. Wu RT, et al. Aging Cell. 2017 Feb;16(1):125-135. doi: 10.1111/acel.12529. Epub 2016 Sep 21. Aging Cell. 2017. PMID: 27653523 Free PMC article. - mRNA methylation in cell senescence.
Casella G, Tsitsipatis D, Abdelmohsen K, Gorospe M. Casella G, et al. Wiley Interdiscip Rev RNA. 2019 Nov;10(6):e1547. doi: 10.1002/wrna.1547. Epub 2019 May 29. Wiley Interdiscip Rev RNA. 2019. PMID: 31144457 Free PMC article. Review. - Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks.
Bilsland AE, Pugliese A, Liu Y, Revie J, Burns S, McCormick C, Cairney CJ, Bower J, Drysdale M, Narita M, Sadaie M, Keith WN. Bilsland AE, et al. Neoplasia. 2015 Sep;17(9):704-715. doi: 10.1016/j.neo.2015.08.009. Neoplasia. 2015. PMID: 26476078 Free PMC article. - Nanomechanical insights: Amyloid beta oligomer-induced senescent brain endothelial cells.
Kulkarni T, Angom RS, Das P, Bhattacharya S, Mukhopadhyay D. Kulkarni T, et al. Biochim Biophys Acta Biomembr. 2019 Dec 1;1861(12):183061. doi: 10.1016/j.bbamem.2019.183061. Epub 2019 Sep 9. Biochim Biophys Acta Biomembr. 2019. PMID: 31513781 Free PMC article. - Adult Stem Cells and Diseases of Aging.
Boyette LB, Tuan RS. Boyette LB, et al. J Clin Med. 2014 Jan 21;3(1):88-134. doi: 10.3390/jcm3010088. J Clin Med. 2014. PMID: 24757526 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources